Skip to main content
. 2016 Mar 14;16:214. doi: 10.1186/s12885-016-2260-y

Fig. 2.

Fig. 2

In the subpopulation of patients with ALP-Bouncing 68 % of patients had a PSA-decline of ≥50 % and 24 % even had a decline of ≥90 %. In patients without ALP-Bouncing only 30 % showed a PSA-decline of ≥50 % and only 5 % declined by ≥90 % (all p < 0.001)